Esketamine, a Treatment for Depression, Receives FDA Approval
Esketamine, a Treatment for Depression, Receives FDA Approval
The nasal spray to ease intractable depression appears on the US market after decades without novel antidepressant treatments.
Esketamine, a Treatment for Depression, Receives FDA Approval
Esketamine, a Treatment for Depression, Receives FDA Approval

The nasal spray to ease intractable depression appears on the US market after decades without novel antidepressant treatments.

The nasal spray to ease intractable depression appears on the US market after decades without novel antidepressant treatments.

anti-depressants
Young Brain Cells Silence Old Ones to Quash Anxiety
Young Brain Cells Silence Old Ones to Quash Anxiety
Ruth Williams | Jun 27, 2018
In adult mice, neurogenesis increases social confidence by suppressing the activity of mature neurons.
SSRI Consumption During Pregnancy Linked to Changes in Babies’ Brains
SSRI Consumption During Pregnancy Linked to Changes in Babies’ Brains
Ashley Yeager | Apr 9, 2018
MRI data suggest prenatal exposure to the medication increases the volume of brain regions vital to processing emotions.
Neurometabolic Disorders Could Contribute to Depression
Neurometabolic Disorders Could Contribute to Depression
Ben Andrew Henry | Nov 1, 2016
Impairments in the production of neurotransmitters may lead to depression in some patients, preliminary results show, opening new avenues for research.
Researcher Accuses Colleagues of Misconduct
Tia Ghose | Jul 13, 2011
A University of Pennsylvania researcher claims his colleagues put their names on a Big Pharma-financed study of the anti-depressant Paxil, sight unseen.